- Home
- FBNC vs ENOV Comparison
FBNC vs ENOV Comparison
Compare FBNC & ENOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBNC
- ENOV
- Stock Information
- Founded
- FBNC 1934
- ENOV 1995
- Country
- FBNC United States
- ENOV United States
- Employees
- FBNC N/A
- ENOV N/A
- Industry
- FBNC Major Banks
- ENOV Fluid Controls
- Sector
- FBNC Finance
- ENOV Industrials
- Exchange
- FBNC Nasdaq
- ENOV Nasdaq
- Market Cap
- FBNC 2.2B
- ENOV 1.8B
- IPO Year
- FBNC N/A
- ENOV 2008
- Fundamental
- Price
- FBNC $48.95
- ENOV $27.34
- Analyst Decision
- FBNC Buy
- ENOV Strong Buy
- Analyst Count
- FBNC 4
- ENOV 6
- Target Price
- FBNC $56.67
- ENOV $51.17
- AVG Volume (30 Days)
- FBNC 190.3K
- ENOV 850.7K
- Earning Date
- FBNC 10-22-2025
- ENOV 11-06-2025
- Dividend Yield
- FBNC 1.90%
- ENOV N/A
- EPS Growth
- FBNC N/A
- ENOV N/A
- EPS
- FBNC 2.39
- ENOV N/A
- Revenue
- FBNC $364,799,000.00
- ENOV $2,233,266,000.00
- Revenue This Year
- FBNC $40.17
- ENOV $9.13
- Revenue Next Year
- FBNC $12.16
- ENOV $6.39
- P/E Ratio
- FBNC $20.35
- ENOV N/A
- Revenue Growth
- FBNC 0.59
- ENOV 11.57
- 52 Week Low
- FBNC $34.50
- ENOV $25.47
- 52 Week High
- FBNC $56.45
- ENOV $49.75
- Technical
- Relative Strength Index (RSI)
- FBNC 46.52
- ENOV 34.28
- Support Level
- FBNC $47.83
- ENOV $27.52
- Resistance Level
- FBNC $50.97
- ENOV $32.41
- Average True Range (ATR)
- FBNC 1.17
- ENOV 1.45
- MACD
- FBNC -0.04
- ENOV -0.37
- Stochastic Oscillator
- FBNC 37.96
- ENOV 3.45
About FBNC First Bancorp
First Bancorp is a bank holding company. The company is engaged in providing commercial and consumer banking services, mortgage lending, SBA lending, accounts receivable financing and investment advisory services.
About ENOV Enovis Corporation
Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. Its reportable segments are Prevention & Recovery (P&R) and Reconstructive (Recon). The company generates the maximum revenue from the Prevention & Recovery segment, which includes products that are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment provides a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and surgical productivity tools. Geographically, it derives key revenue from the U.S.